ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 121 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,277,573 | -19.1% | 113,538 | +13.8% | 0.00% | – |
| Q2 2023 | $2,814,060 | +106.3% | 99,754 | +25.8% | 0.00% | – |
| Q1 2023 | $1,363,736 | +54.2% | 79,287 | +80.6% | 0.00% | – |
| Q4 2022 | $884,287 | -64.2% | 43,907 | -61.5% | 0.00% | – |
| Q3 2022 | $2,472,000 | +207.8% | 114,121 | +299.5% | 0.00% | – |
| Q2 2022 | $803,000 | -77.2% | 28,568 | -62.5% | 0.00% | – |
| Q1 2022 | $3,519,000 | -70.1% | 76,266 | -45.4% | 0.00% | – |
| Q4 2021 | $11,750,000 | +26.3% | 139,786 | +0.2% | 0.00% | -100.0% |
| Q3 2021 | $9,300,000 | +276.2% | 139,551 | +200.3% | 0.00% | – |
| Q2 2021 | $2,472,000 | +776.6% | 46,473 | +613.9% | 0.00% | – |
| Q1 2021 | $282,000 | -57.5% | 6,510 | -49.1% | 0.00% | – |
| Q4 2020 | $664,000 | – | 12,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradigm Biocapital Advisors LP | 300,434 | $25,254,000 | 7.21% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 2,628,409 | $220,944,000 | 6.56% |
| Avidity Partners Management LP | 2,715,000 | $228,223,000 | 4.84% |
| Matrix Capital Management Company, LP | 4,349,279 | $365,600,000 | 4.07% |
| Affinity Asset Advisors, LLC | 117,500 | $9,877,000 | 3.59% |
| Integral Health Asset Management, LLC | 120,000 | $10,087,000 | 2.79% |
| Ghost Tree Capital, LLC | 80,000 | $6,725,000 | 2.41% |
| Ikarian Capital, LLC | 191,140 | $16,067,000 | 2.39% |
| Tri Locum Partners LP | 23,632 | $1,987,000 | 0.78% |
| Eventide Asset Management | 529,000 | $44,468,000 | 0.57% |